{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:33:33Z","timestamp":1765294413783},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T00:00:00Z","timestamp":1268870400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Clin Pharmacol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1472-6904-10-6","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T19:14:12Z","timestamp":1268939652000},"source":"Crossref","is-referenced-by-count":21,"title":["Use of analgesics in intentional drug overdose presentations to hospital before and after the withdrawal of distalgesic from the Irish market"],"prefix":"10.1186","volume":"10","author":[{"given":"Paul","family":"Corcoran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Reulbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen S","family":"Keeley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan J","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Hawton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Arensman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,18]]},"reference":[{"issue":"8017","key":"87_CR1","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0140-6736(77)91212-0","volume":"1","author":"DJ Carson","year":"1977","unstructured":"Carson DJ: Fatal dextropropoxyphene poisoning in Northern Ireland. Review of 30 cases. Lancet. 1977, 1 (8017): 894-897. 10.1016\/S0140-6736(77)91212-0.","journal-title":"Lancet"},{"issue":"7397","key":"87_CR2","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/bmj.326.7397.1006","volume":"326","author":"K Hawton","year":"2003","unstructured":"Hawton K, Simkin S, Deeks J: Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings. Bmj. 2003, 326 (7397): 1006-1008. 10.1136\/bmj.326.7397.1006.","journal-title":"Bmj"},{"issue":"3","key":"87_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/qjmed\/hci026","volume":"98","author":"S Simkin","year":"2005","unstructured":"Simkin S, Hawton K, Sutton L, Gunnell D, Bennewith O, Kapur N: Co-proxamol and suicide: preventing the continuing toll of overdose deaths. Q J Med. 2005, 98 (3): 159-170.","journal-title":"Q J Med"},{"issue":"9","key":"87_CR4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5694\/j.1326-5377.1986.tb101046.x","volume":"144","author":"C Hardwicke","year":"1986","unstructured":"Hardwicke C, Holt L, James R, Smith AJ: Trends in self-poisoning with drugs in Newcastle, New South Wales, 1980-1982. Med J Aust. 1986, 144 (9): 453-454.","journal-title":"Med J Aust"},{"key":"87_CR5","doi-asserted-by":"publisher","first-page":"b2270","DOI":"10.1136\/bmj.b2270","volume":"338","author":"K Hawton","year":"2009","unstructured":"Hawton K, Bergen H, Simkin S, Brock A, Griffiths C, Romeri E, Kapur N, Gunnell D: Impact of withdrawal of co-proxamol: Time series analysis of prescribing and drug poisoning deaths in England and Wales. Bmj. 2009, 338: b2270-10.1136\/bmj.b2270.","journal-title":"Bmj"},{"key":"87_CR6","volume-title":"Report for the Swedish National Board of Forensic Medicine and Medical Products Agency","author":"U Jonasson","year":"2004","unstructured":"Jonasson U, Jonasson B: Restrictions on the prescribing of dextropropoxyphene (DXP) - effects on sales and cases of fatal poisoning. Report for the Swedish National Board of Forensic Medicine and Medical Products Agency. 2004, [ http:\/\/www.rmv.se\/fileadmin\/RMVFiles\/pdf\/publicerat\/dxp-report.pdf ]"},{"issue":"2","key":"87_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-2125.2008.03206.x","volume":"66","author":"EA Sandilands","year":"2008","unstructured":"Sandilands EA, Bateman DN: Co-proxamol withdrawal has reduced suicide from drugs in Scotland. Br J Clin Pharmacol. 2008, 66 (2): 290-293. 10.1111\/j.1365-2125.2008.03206.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"1-2","key":"87_CR8","first-page":"141","volume":"12","author":"E Segest","year":"1993","unstructured":"Segest E, Harris CN, Bay H: Dextropropoxyphene deaths in Denmark from the health authority point of view. Med Law. 1993, 12 (1-2): 141-151.","journal-title":"Med Law"},{"issue":"2","key":"87_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1600-0447.1992.tb01451.x","volume":"85","author":"S Platt","year":"1992","unstructured":"Platt S, Bille-Brahe U, Kerkhof A, Schmidtke A, Bjerke T, Crepet P, De Leo D, Haring C, Lonnqvist J, Michel K: Parasuicide in Europe: the WHO\/EURO multicentre study on parasuicide. I. Introduction and preliminary analysis for 1989. Acta Psychiatr Scand. 1992, 85 (2): 97-104. 10.1111\/j.1600-0447.1992.tb01451.x.","journal-title":"Acta Psychiatr Scand"},{"key":"87_CR10","volume-title":"National Parasuicide Registry Ireland Annual Report 2006-2007","author":"National Suicide Research Foundation","year":"2008","unstructured":"National Suicide Research Foundation: National Parasuicide Registry Ireland Annual Report 2006-2007. 2008, Cork: National Suicide Research Foundation, [ http:\/\/www.nsrf.ie\/npr2006_07.htm ]"},{"key":"87_CR11","volume-title":"Cancer incidence in five continents","author":"J Waterhouse","year":"1976","unstructured":"Waterhouse J, Muir C, Correa P, Powell J: Cancer incidence in five continents. 1976, Lyon: IARC"},{"issue":"Suppl 1","key":"87_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1027\/0227-5910.28.S1.4","volume":"28","author":"K Hawton","year":"2007","unstructured":"Hawton K: Restricting access to methods of suicide: Rationale and evaluation of this approach to suicide prevention. Crisis. 2007, 28 (Suppl 1): 4-9.","journal-title":"Crisis"},{"key":"87_CR13","volume-title":"Dublin","author":"Statutory Instrument (SI 150)","year":"2001","unstructured":"Statutory Instrument (SI 150): Medicinal Products (Control of Paracetamol) Regulations. Dublin. 2001"}],"container-title":["BMC Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-10-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6904-10-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-10-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T04:13:46Z","timestamp":1591157626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1186\/1472-6904-10-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,18]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["87"],"URL":"https:\/\/doi.org\/10.1186\/1472-6904-10-6","relation":{},"ISSN":["1472-6904"],"issn-type":[{"value":"1472-6904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,18]]},"article-number":"6"}}